Please Wait.....
Report
United States Clinical Trial Investigative Site Network Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Oncology, Cardiology, CNS Conditions, Pain Management, Endocrine, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
Market Report I 2025-05-23 I 84 Pages I TechSci Research
Market Overview
The United States Clinical Trial Investigative Site Network Market was valued at USD 2.88 billion in 2024 and is projected to reach USD 4.51 billion by 2030, growing at a CAGR of 7.73%. The market is expanding steadily, driven by the growing complexity of clinical trials and the increasing need for specialized infrastructure. Rising incidences of chronic illnesses such as cancer, cardiovascular, and neurological diseases are pushing pharmaceutical and biotech firms to speed up drug development through partnerships with site networks. These networks enhance efficiency through centralized coordination, experienced investigators, and improved patient recruitment. The market is also being shaped by the growing adoption of decentralized and hybrid trial models, supported by digital health tools and remote monitoring technologies. Artificial intelligence and machine learning are being utilized to optimize site selection, enrollment forecasts, and protocol design. With the growing emphasis on precision medicine, investigative networks are adjusting recruitment and operational models to support personalized trial approaches.
Key Market Drivers
Rising Number of Clinical Trials and Drug Development Activities
An increase in clinical trials and drug development activities is a primary growth driver for the United States Clinical Trial Investigative Site Network Market. Growing investments by pharmaceutical and biotechnology firms in innovative therapies have intensified the demand for clinical trials. As of 2024, the U.S. accounted for over 35% of all global clinical trials, underscoring its leadership in the research landscape. The surge in trials for biologics, gene therapies, immunotherapies, and precision medicine by sponsors such as pharma companies, CROs, and academic institutions has amplified the reliance on investigative site networks. Furthermore, expedited approval pathways for breakthrough drugs have encouraged trial expansion across multiple U.S. regions, reinforcing the role of site networks in accelerating therapeutic development.
Key Market Challenges
Patient Recruitment and Retention Difficulties
Recruiting and retaining patients remains a persistent hurdle in the United States Clinical Trial Investigative Site Network Market. Recruitment is hampered by limited public awareness, complex eligibility requirements, and safety concerns associated with experimental treatments. Specialized trials, particularly in oncology, rare diseases, and CNS disorders, face difficulties in identifying suitable participants, often delaying study timelines and increasing costs. Retention presents another issue, as patients may discontinue participation due to side effects, time constraints, travel demands, or lack of perceived benefits. These barriers are particularly pronounced for individuals in rural or underserved locations. To mitigate these challenges, site networks are incorporating digital tools like telemedicine, mobile health apps, and wearable technology to simplify participation and maintain engagement. While these tools offer promise, patient enrollment and retention continue to pose significant obstacles, necessitating ongoing innovation to support market growth.
Key Market Trends
Rising Adoption of Decentralized and Hybrid Clinical Trials
The shift toward decentralized and hybrid clinical trial models is a defining trend in the United States Clinical Trial Investigative Site Network Market. Traditional models often require frequent site visits, which can be burdensome for patients, especially those in remote locations. Decentralized trials leverage telehealth, wearable technology, and mobile applications to allow participants to engage remotely, minimizing the need for in-person visits. Hybrid trials combine on-site and virtual components to offer greater flexibility and accessibility. These models are particularly useful in global or geographically diverse studies. Investigative site networks are increasingly integrating technologies that support decentralized approaches, such as real-time monitoring tools, digital biomarkers, and patient engagement platforms. These innovations improve compliance, streamline data collection, and boost patient retention, offering a more adaptive and efficient framework for clinical research.
Key Market Players
- PAREXEL International Corporation
- ICON plc
- IQVIA Holdings Inc.
- Velocity Clinical Research Inc.
- Elligo Health Research, Inc.
- WCG Clinical, Inc.
- Access Clinical Trials Inc.
- FOMAT Medical Research, Inc.
- Charles River Laboratories International, Inc.
- ePharmaSolutions, Inc.
Report Scope:
In this report, the United States Clinical Trial Investigative Site Network Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United States Clinical Trial Investigative Site Network Market, By Phase:
o Phase I
o Phase II
o Phase III
o Phase IV
- United States Clinical Trial Investigative Site Network Market, By Therapeutic Area:
o Oncology
o Cardiology
o CNS Conditions
o Pain Management
o Endocrine
o Others
- United States Clinical Trial Investigative Site Network Market, By End User:
o Pharmaceutical & Biopharmaceutical Companies
o Medical Device Companies
o Others
- United States Clinical Trial Investigative Site Network Market, By Region:
o North-East
o Mid-West
o West
o South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Clinical Trial Investigative Site Network Market.
Available Customizations:
United States Clinical Trial Investigative Site Network Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Clinical Trial Investigative Site Network Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Phase (Phase I, Phase II, Phase III, Phase IV)
5.2.2. By Therapeutic Area (Oncology, Cardiology, CNS Conditions, Pain Management, Endocrine, Others)
5.2.3. By End User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North-East Clinical Trial Investigative Site Network Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Phase
6.2.2. By Therapeutic Area
6.2.3. By End User
7. Mid-West Clinical Trial Investigative Site Network Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Phase
7.2.2. By Therapeutic Area
7.2.3. By End User
8. West Clinical Trial Investigative Site Network Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Phase
8.2.2. By Therapeutic Area
8.2.3. By End User
9. South Clinical Trial Investigative Site Network Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Phase
9.2.2. By Therapeutic Area
9.2.3. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. United States Clinical Trial Investigative Site Network Market: SWOT Analysis
15. Porter's Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. PAREXEL International Corporation
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. ICON plc
16.3. IQVIA Holdings Inc.
16.4. Velocity Clinical Research Inc.
16.5. Elligo Health Research, Inc.
16.6. WCG Clinical, Inc.
16.7. Access Clinical Trials Inc.
16.8. FOMAT Medical Research, Inc.
16.9. Charles River Laboratories International, Inc.
16.10. ePharmaSolutions, Inc.
17. Strategic Recommendations
18. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security